Accumulating evidence in recent years suggests that parkin dysfunction might be involved in the pathogenesis of other neurodegenerative diseases such as Alzheimer’s disease [238]. This evidence concerns the gene PRKN and early-onset autosomal dominant Alzheimer disease.